When Weight Loss Becomes the Standard Again: GLP-1 Medications, Eating Disorders, and the Women Being Left Behind

Explore how GLP-1 medications such as semaglutide and tirzepatide are reshaping women’s body image, eating disorder recovery, and access to care. This trauma-informed article examines renewed pressure to be thin, risks for women with disordered eating, socioeconomic disparities, and why mental health screening must remain central to weight-loss treatment. Learn how compassionate care can reduce real harm.

Read More